Ledger.Open graph →
SEC Form D · filed September 15, 2017

aTYR PHARMA INC

Offering
$45.8M
Sold
$45.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

John K. Clarke · San Diego, CADirectorJames C. Blair · San Diego, CADirectorJeffrey S. Hatfield · San Diego, CADirectorJohn D. Mendlein · San Diego, CAExec · DirectorJohn T. Blake · San Diego, CAExecAmir H. Nashat, Sc.D · San Diego, CADirectorSanjay S. Shukla · San Diego, CAExecMark P. Goldberg · San Diego, CADirectorSanuj K. Ravindran · San Diego, CAExecNancy D. Krueger · San Diego, CAExecJohn K. Clarke · CAMBRIDGE, MADirectorPaul K. Schimmel · San Diego, CADirectorSrini S. Akkaraju · San Diego, CADirectorTimothy P. Coughlin · SAN DIEGO, CADirectorJames C. Blair · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗